Drenth JPH - Search Results

1

Carbamazepine intervention in a patient with efavirenz-induced liver injury.

Jacobs TG, Burger DM, Pranger AD, Khoo SH, Drenth JPH, van Crevel R. Jacobs TG, et al. Among authors: drenth jph. AIDS. 2019 May 1;33(6):1097-1098. doi: 10.1097/QAD.0000000000002116. AIDS. 2019. PMID: 30946165 No abstract available.

2

Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock.

Ferwerda B, Alonso S, Banahan K, McCall MB, Giamarellos-Bourboulis EJ, Ramakers BP, Mouktaroudi M, Fain PR, Izagirre N, Syafruddin D, Cristea T, Mockenhaupt FP, Troye-Blomberg M, Kumpf O, Maiga B, Dolo A, Doumbo O, Sundaresan S, Bedu-Addo G, van Crevel R, Hamann L, Oh DY, Schumann RR, Joosten LA, de la Rúa C, Sauerwein R, Drenth JP, Kullberg BJ, van der Ven AJ, Hill AV, Pickkers P, van der Meer JW, O'Neill LA, Netea MG. Ferwerda B, et al. Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10272-7. doi: 10.1073/pnas.0811273106. Epub 2009 Jun 9. Proc Natl Acad Sci U S A. 2009. PMID: 19509334 Free PMC article.

3

Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment.

Van Vlerken LG, Van Soest H, Janssen MP, Boland GJ, Drenth JP, Burger DM, Siersema PD, Van Erpecum KJ. Van Vlerken LG, et al. Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1308-15. doi: 10.1097/MEG.0b013e32833e784d. Eur J Gastroenterol Hepatol. 2010. PMID: 20729740 Clinical Trial.

4

Ribavirin plasma concentration measurements in patients with hepatitis C: early ribavirin concentrations predict steady-state concentrations.

Slavenburg S, Huntjens-Fleuren HW, Dofferhoff TS, Richter C, Koopmans PP, Verwey-Van Wissen CP, Drenth JP, Burger DM. Slavenburg S, et al. Ther Drug Monit. 2011 Feb;33(1):40-4. doi: 10.1097/FTD.0b013e318205f892. Ther Drug Monit. 2011. PMID: 21191316

5

Lack of a clinically significant drug-drug interaction in healthy volunteers between the HCV protease inhibitor boceprevir and the proton pump inhibitor omeprazole.

de Kanter CT, Colbers AP, Blonk MI, Verweij-van Wissen CP, Schouwenberg BJ, Drenth JP, Burger DM. de Kanter CT, et al. J Antimicrob Chemother. 2013 Jun;68(6):1415-22. doi: 10.1093/jac/dkt032. Epub 2013 Feb 20. J Antimicrob Chemother. 2013. PMID: 23429642 Free article. Clinical Trial.

6

Measuring ribavirin concentrations during the earliest stages of antiviral therapy for hepatitis C: potential relevance for treatment outcome.

van Vlerken LG, de Kanter CT, Boland GJ, van Loon AM, van Soest H, Koek GH, Drenth JP, Siersema PD, van Erpecum KJ, Burger DM. van Vlerken LG, et al. Ther Drug Monit. 2013 Aug;35(4):546-51. doi: 10.1097/FTD.0b013e31828a9fbf. Ther Drug Monit. 2013. PMID: 23851908 Clinical Trial.

7

Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations.

de Kanter CT, Drenth JP, Arends JE, Reesink HW, van der Valk M, de Knegt RJ, Burger DM. de Kanter CT, et al. Clin Pharmacokinet. 2014 May;53(5):409-27. doi: 10.1007/s40262-014-0142-5. Clin Pharmacokinet. 2014. PMID: 24723109 Review.

8

The ARRIBA concept: adequate resorption of ribavirin.

de Kanter CT, Koning L, Berden FA, Wasmuth JC, Grintjes-Huisman KJ, Becker B, Colbers AP, Roukens MM, Rockstroh JK, Drenth JP, de Knegt RJ, Dofferhoff AS, Burger DM. de Kanter CT, et al. Antivir Ther. 2015;20(5):515-20. doi: 10.3851/IMP2935. Epub 2015 Jan 19. Antivir Ther. 2015. PMID: 25599333 Clinical Trial.

9

Lower Ribavirin Plasma Concentrations in HCV/HIV-Coinfected Patients Than in HCV-Monoinfected Patients Despite Similar Dosage.

Deenen MJ, de Kanter CT, Dofferhoff AS, Grintjes-Huisman KJ, van der Ven AJ, Fleuren HW, Gisolf EH, Koopmans PP, Drenth JP, Burger DM. Deenen MJ, et al. Ther Drug Monit. 2015 Dec;37(6):751-5. doi: 10.1097/FTD.0000000000000226. Ther Drug Monit. 2015. PMID: 26102531

10

Ribavirin concentration determines treatment success of first-generation DAA-based chronic HCV therapy.

de Kanter CT, Buti M, DeMasi R, Ouwerkerk-Mahadevan S, Dofferhoff AS, Witek J, Drenth JP, Zeuzem S, Burger DM. de Kanter CT, et al. Antivir Ther. 2016;21(2):153-9. doi: 10.3851/IMP2994. Epub 2015 Sep 17. Antivir Ther. 2016. PMID: 26378941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

521 results

Search Page